Biosimilars CROs

Hyderabad-based mid-size CRO operating across India, the Philippines, Thailand, Vietnam, and the Middle East, providing Phase I-IV clinical trial services and regulatory affairs.

Budapest-based CRO providing full-service clinical trial management across Hungary and Central Europe, with capabilities in oncology, rare disease, and biosimilar clinical programs.

Singapore-based specialty CRO providing preclinical pharmacology, toxicology, and early clinical development services with particular expertise in biologics and biosimilar characterization.

Clinical research division of Brazil's largest national pharmaceutical company, conducting Phase I-IV clinical trials across 10+ Brazilian sites with particular expertise in generics and biosimilars.

Korean CDMO providing development and GMP manufacturing of solid oral dosage forms, injectables, and biosimilars, with FDA and EMA-inspected facilities serving global markets.

Global regulatory affairs and drug development consulting firm providing IND/NDA/MAA filing support, clinical development strategy, and pharmacovigilance services.